Kalehua Capital Management LLC
Filing Date
Global Rank
#5,357
/ 8,603
▲ 888
· as of Mar 2026
Top Industry
Biotechnology
95.7%
3Y Alpha vs SPY
+134.2%
Period ended 3 months ago
Filed May 15, 2026 · 55d
2 quarters · since Dec 2025
Clone Performance
Feb 2026–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+43.4%
SPY
+9.6%
Annualised alpha
+121.7%
Max drawdown
−13.6%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
24 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
13.2%
−5.1 pts
Top 5
45.4%
−9.9 pts
Top 10
70.8%
−11.1 pts
HHI
651
Diversified−228
Portfolio Trend
2 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 99.6% | $115,603,236 |
| Basic Materials | 0.4% | $496,980 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| IKT | Inhibikase Therapeutics, Inc. | +2,071,890 | 3,821,890 | $6,420,775 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
9 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| MANE | Veradermics, Inc | 145,695 | $9,200,638 | |
| ACRS | Aclaris Therapeutics, Inc. | 1,832,365 | $6,871,368 | |
| QURE | uniQure N.V. | 291,109 | $4,759,632 | |
| DMRA | Damora Therapeutics, Inc. | 139,000 | $3,600,100 | |
| GOSS | Gossamer Bio, Inc. | 10,236,293 | $3,367,740 | |
| PEPG | PepGen Inc. | 1,000,000 | $1,770,000 | |
| TIL | Instil Bio, Inc. | 183,030 | $1,508,167 | |
| KRRO | Korro Bio, Inc. | 109,376 | $1,238,136 | |
| LOOP | Loop Industries, Inc. | 347,539 | $496,980 | |
| No positions match the current search. | ||||
24 positions ·
$116,100,216 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| XFOR |
X4 Pharmaceuticals, Inc
Healthcare
|
Held | 3,722,840 | $15,375,329 | 13.24% | |
| SRZN |
Surrozen, Inc./DE
Healthcare
|
Held | 385,178 | $11,220,235 | 9.66% | |
| MANE |
Veradermics, Inc
Healthcare
|
NEW | 145,695 | $9,200,638 | 7.92% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
Held | 901,457 | $8,969,497 | 7.73% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
Held | 197,072 | $7,900,616 | 6.80% | |
| ACRS |
Aclaris Therapeutics, Inc.
Healthcare
|
NEW | 1,832,365 | $6,871,368 | 5.92% | |
| IKT |
Inhibikase Therapeutics, Inc.
Healthcare
|
Added | 3,821,890 | $6,420,775 | 5.53% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
Held | 118,524 | $5,813,602 | 5.01% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Held | 198,772 | $5,615,309 | 4.84% | |
| QURE |
uniQure N.V.
Healthcare
|
NEW | 291,109 | $4,759,632 | 4.10% | |
| SEPN |
Septerna, Inc.
Healthcare
|
Held | 194,544 | $4,674,892 | 4.03% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
Held | 819,692 | $4,532,896 | 3.90% | |
| LONA |
LeonaBio, Inc.
Healthcare
|
Held | 393,701 | $4,047,246 | 3.49% | |
| DMRA |
Damora Therapeutics, Inc.
Healthcare
|
NEW | 139,000 | $3,600,100 | 3.10% | |
| GOSS |
Gossamer Bio, Inc.
Healthcare
|
NEW | 10,236,293 | $3,367,740 | 2.90% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
Held | 175,734 | $3,275,681 | 2.82% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
Held | 74,465 | $2,852,009 | 2.46% | |
| PEPG |
PepGen Inc.
Healthcare
|
NEW | 1,000,000 | $1,770,000 | 1.52% | |
| TIL |
Instil Bio, Inc.
Healthcare
|
NEW | 183,030 | $1,508,167 | 1.30% | |
| TNYA |
Tenaya Therapeutics, Inc.
Healthcare
|
Held | 2,000,000 | $1,384,000 | 1.19% | |
| KRRO |
Korro Bio, Inc.
Healthcare
|
NEW | 109,376 | $1,238,136 | 1.07% | |
| KLRS |
Kalaris Therapeutics, Inc.
Healthcare
|
Reduced | 135,585 | $782,325 | 0.67% | |
| LOOP |
Loop Industries, Inc.
Basic Materials
|
NEW | 347,539 | $496,980 | 0.43% | |
| DMAC |
DiaMedica Therapeutics Inc.
Healthcare
|
Reduced | 62,488 | $423,043 | 0.36% |